KKR's Satvat Says Volatility Is Good for the Firm

The video discusses the healthcare market's resilience and growth opportunities, especially post-pandemic. It highlights the focus on innovation, such as mRNA technology, and the importance of strategic partnerships. Investment strategies like 'teams and themes' are explored, emphasizing the role of strong executives and scalable platforms. The discussion also covers macroeconomic factors affecting the sector, including volatility and inflation, and the importance of long-term patient capital.

What are the key takeaways from the JP Morgan Healthcare Conference regarding growth opportunities in healthcare?

How has the focus on messenger RNA technology changed during the pandemic?

What are the implications of the supply chain changes in the healthcare sector post-pandemic?

How does the current economic environment affect technology stocks in the healthcare sector?

In what ways can private equity firms like KKR leverage their capital in the current healthcare market?

What role does innovation play in the healthcare investment landscape according to the discussion?

What are the long-term benefits of investing in healthcare according to the speaker?